ITM Power: The ÂŁ40m Government Bet and the Long Wait for a ÂŁ46.5m Decision
23.06.2026 - 13:01:58 | boerse-global.de
A 4.9% slide in Tuesday’s session erased some of the lustre from ITM Power’s recent rally, but the move had less to do with the company’s turnaround story than with the mechanics of index rebalancing. The electrolyser maker was added to the MSCI UK Small Cap Index at the end of May, forcing passive funds to accumulate shares. Now, arbitrageurs are cashing in those gains, while soft purchasing-manager data has weighed on the broader hydrogen sector. The stock closed at €1.49, down 4.92% on the day, though it still sports a year-to-date advance of 105.24%. From its February trough of €0.65, the rise is even more striking at 115%.
Beneath the technical noise, a far more consequential story is unfolding. Great British Energy, the UK state investment vehicle, now holds 10.4% of the company after injecting £40m through a capital increase. The cash is earmarked for automating production at the company’s Sheffield facility and for commercialising the “Chronos” stack platform – the technological linchpin of the turnaround. Chronos is designed to boost energy efficiency by 10% over current-generation PEM electrolysers while slashing manufacturing costs by roughly 40%. The target is a certified annual production capacity of 1 GW, though the final certification remains subject to pending approvals.
A much larger state cheque hinges on a regulatory verdict due on 30 June 2026. On that date, the UK’s Competition and Markets Authority (CMA) will rule on an additional £46.5m grant from the Department for Energy Security. If approved, the extra funding would materially accelerate the ramp-up of automated manufacturing and lock in the financing for Chronos’s industrialisation. The order book already stands at £152m, with 71% of those contracts now considered profitable – a marked departure from the low-margin legacy deals that once weighed on margins.
Should investors sell immediately? Or is it worth buying ITM Power?
For the current financial year, management has guided for revenue of up to ÂŁ43m, with the path to profitability hinging on standardised, high-volume products rather than bespoke projects. The break-even horizon is set for 2028, when the Chronos line is due to reach full commercial operation. Strategic offtake agreements in Scotland are intended to secure demand as production scales.
Analyst views remain split. Morgan Stanley sees the stock at 170 pence (roughly €2.00), pointing to the state-backed expansion plan and the potential for a clean energy tailwind. Berenberg is more cautious, with a target of 110 pence (€1.30), flagging execution risks as automated production competes in a global market that is still absorbing capacity. At the current price of €1.57, the shares trade in neutral territory according to the RSI (45), leaving room for either a re-rating or a retracement depending on how the next catalysts unfold.
The coming weeks will test whether the state’s vote of confidence can overcome the market’s short-term jitters. The CMA decision, though 12 months away, casts a long shadow over the stock’s valuation. If the grant comes through, the financial foundation for Chronos’s roll-out will be largely secured – and Morgan Stanley’s bullish case will look a lot more plausible.
Ad
ITM Power Stock: New Analysis - 23 June
Fresh ITM Power information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
